NIH’s Abrupt Grant Cuts Threaten HIV Progress and Global Health Security
We urge swift action by members of Congress to stand up for investments in research and call for the reversal of the grant terminations.
Eliminating HIV Prevention at CDC Would Harm Efforts to End the HIV Epidemic
Cutting off the funding and the technical assistance that state health departments and community-based providers across the country rely on for HIV education, HIV testing and pre-exposure prophylaxis, or PrEP, programs would have devastating health and economic consequences.
IDSA and HIVMA Join Rally to Protect Science & Public Health
The Infectious Diseases Society of America and the HIV Medicine Association will be Standing Up for Science at a rally March 7, 12–4 p.m. ET, in Washington, D.C., and we encourage members to participate in rallies planned in more than 30 cities around the United States.
IDSA & HIVMA Raise Alarm About Access to HIV Care Following USAID, PEPFAR Cuts
IDSA and HIVMA are deeply concerned by the abrupt cancellation of 92% of U.S. Agency for International Development foreign assistance awards and the impact the action will have on many, including the more than 20 million people to whom our country has made a commitment to provide access to HIV treatment through the President’s Emergency Plan for AIDS Relief.
IDSA and HIVMA Reaffirm Commitment to Inclusion, Diversity, Access and Equity
As we navigate the rapid changes in federal policies under the new Administration, the Infectious Diseases Society of America and the HIV Medicine Association remain dedicated to improving health outcomes for all and strengthening the public health system.
Statement From HIVMA Chair Colleen Kelley, MD, MPH, FIDSA, in Response to NIH Funding Cuts
Research programs across the country are dependent on sufficient funding to execute complex, cutting-edge biomedical research that advances health for all people.
Removal of HIV- and LGBTQ-Related CDC Webpages Creates Dangerous Gaps in Scientific Information
The removal these resources from the websites of the CDC and other health agencies is deeply concerning and creates a dangerous gap in scientific information and data to monitor and respond to disease outbreaks.
HIVMA Honors Outstanding Achievements in HIV Clinical Education and Research With 2024 Awards
The HIV Medicine Association is pleased to recognize three members during IDWeek 2024 for their contributions to advancing the field of HIV medicine.
HIVMA Names Colleen Kelley, MD, MPH, FIDSA, Chair of the Board
The HIV Medicine Association is pleased to announce the election of Colleen Kelley, MD, MPH, FIDSA, as the new chair of its Board of Directors.
Senate Appropriations Bill Offers Lifeline for Key HIV-Related Programs, but Fails to Fund Important ID/HIV Workforce Program
The Senate bill also rejects the House proposal to split up the National Institute of Allergy and Infectious Diseases with significantly reduced funding.
House LHHS Appropriations Bill Harmful to HIV Response and ID Research
HIVMA is deeply concerned by the impact the House Labor, Health and Human Services, and Education bill would have on our ability to respond to the HIV epidemic and other infectious diseases.
IDSA and HIVMA Response to New CDC Guidelines on Doxycycline as Post-Exposure Prophylaxis
IDSA and HIVMA welcome the Centers for Disease Control and Prevention’s guidelines for implementing doxycycline as post-exposure prophylaxis, or doxy PEP, to prevent sexually transmitted infections.